GenScript/ProBio

About GenScript

GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Founded in 2002, GenScript has an established global presence across North America, Europe, the Greater China, and Asia Pacific. GenScript's businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy.

GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.

About ProBio

ProBio is a New Jersey-based fully integrated end-to-end contract development and manufacturing organization (CDMO) that focuses on enabling biotech and pharmaceutical companies to accelerate novel drug development and supply for clinical trials through to commercialization.

ProBio develops technology-driven proprietary platform processes to support the full lifecycle of biologics drug development and manufacturing of next generation medicine: biologics and advanced therapies. Our technical and operational expertise spans the discovery, development, and drug substance or drug product (DS/DP) manufacturing of antibody-based therapeutics, including monoclonal, bispecific, and multi-specific antibodies, recombinant proteins, plasmid DNA, viral vectors, mRNA, and vaccines. Additionally, we provide specialized integrated services in process development, bioanalytical development, formulation and in vitro/in vivo pharmacology.